Twitter censors user for tweeting a PUBMED study on Ivermectin: A Twitter user shared a screenshot of another user's censorship notice. The censored user tweeted "New2Trip: Efficacy of single-dose & double-dose ivermectin early treatment in preventing progression to hospitalization in mild COVID-19: multi-arm, parallel-group randomized, double-blind, placebo-controlled trial." The user included a link to the PUBMED study of the same title in the tweet. Twitter claimed this violated its "policy on spreading misleading and potentially harmful information related to COVID-19." The user's account was locked until they deleted the tweet.